San Diego, CA, United States of America

Myocardial Therapeutics, Inc.

USPTO Granted Patents = 5

% Expired Patents = 20.0

Forward Citations = 525

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Ran Kornowski (3 out of 27 patents)

silverMedal Stephen E Epstein (3 out of 11 patents)

bronzeMedal Shmuel Fuchs (3 out of 3 patents)

4.  Kazuo Sasamine (2 out of 13 patents)

5.  Kenneth W Carpenter (2 out of 8 patents)

6.  E Thomas Malphus (2 out of 2 patents)

7.  Michelle Fourmont (2 out of 3 patents)

8.  Hong Li (2 out of 12 patents)

9.  Martin B Leon (1 out of 6 patents)


5 patents:

Company Overview
Myocardial Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for heart diseases. Our cutting-edge research aims to revolutionize treatment options for patients with myocardial infarction and other cardiac conditions. With a team of experienced scientists and a commitment to improving patient outcomes, we strive to bring new, life-saving treatments to market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#875 in San Diego, CA

#12,073 in California

#51,644 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 525

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Myocardial Therapeutics, Inc.. Retrieved from https://idiyas.com/company/myocardial-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…